CVS Health (CVS) Now Covered by Deutsche Bank

Investment analysts at Deutsche Bank started coverage on shares of CVS Health (NYSE:CVS) in a note issued to investors on Monday. The brokerage set a “buy” rating and a $90.00 price target on the pharmacy operator’s stock. Deutsche Bank’s price objective suggests a potential upside of 26.74% from the company’s current price.

A number of other research firms have also commented on CVS. Royal Bank Of Canada initiated coverage on shares of CVS Health in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price objective on the stock. Robert W. Baird restated a “hold” rating and issued a $77.00 price objective on shares of CVS Health in a research note on Friday, October 27th. Loop Capital initiated coverage on shares of CVS Health in a research note on Thursday, August 24th. They issued a “hold” rating and a $83.00 price objective on the stock. Jefferies Group set a $86.00 price objective on shares of CVS Health and gave the company a “hold” rating in a research note on Wednesday, October 18th. Finally, Wolfe Research lowered shares of CVS Health from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $89.00 to $82.00 in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.35.

CVS Health (NYSE CVS) opened at $71.01 on Monday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The company has a market cap of $72,621.40, a price-to-earnings ratio of 12.56, a price-to-earnings-growth ratio of 1.23 and a beta of 0.89. CVS Health has a one year low of $66.45 and a one year high of $84.72.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The company had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. CVS Health’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.64 earnings per share. equities research analysts anticipate that CVS Health will post 5.9 EPS for the current year.

In related news, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the sale, the executive vice president now owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. In the last ninety days, insiders sold 714,125 shares of company stock worth $58,119,381. Insiders own 0.61% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in CVS. Horan Capital Advisors LLC. raised its position in CVS Health by 3.2% during the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after acquiring an additional 1,000 shares during the last quarter. Community Bank N.A. raised its position in CVS Health by 7.3% during the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after acquiring an additional 1,362 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in CVS Health by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after acquiring an additional 5,478 shares during the last quarter. Midwest Investment Management LLC raised its position in CVS Health by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after acquiring an additional 1,245 shares during the last quarter. Finally, Fiduciary Trust Co. raised its position in CVS Health by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after acquiring an additional 4,265 shares during the last quarter. 82.24% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “CVS Health (CVS) Now Covered by Deutsche Bank” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://ledgergazette.com/2017/12/06/cvs-health-cvs-now-covered-by-deutsche-bank.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply